Santen Pharmaceutical Co., Ltd.
SNPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $63,560,000 | $84,578,000 | $92,997,000 | $77,851,000 |
| Short-Term Investments | $2,524,000 | $0 | $997,000 | $0 |
| Receivables | $424,481 | $67,398,000 | $71,759,000 | $69,066,000 |
| Inventory | $59,282,000 | $59,247,000 | $51,590,000 | $49,998,000 |
| Other Curr. Assets | -$124,471,280 | $10,195,000 | $6,957,000 | $8,223,000 |
| Total Curr. Assets | $1,319,200 | $221,418,000 | $224,300,000 | $205,138,000 |
| Property Plant & Equip (Net) | $74,812,000 | $72,715,000 | $72,954,000 | $74,387,000 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $77,583,000 | $73,677,000 | $75,467,000 | $79,612,000 |
| Long-Term Investments | $141,946 | $137,198 | $26,539,000 | $28,940,000 |
| Tax Assets | $10,614,000 | $0 | $10,017,000 | $0 |
| Other NC Assets | -$161,839,581 | $40,175,802 | $1,000 | $10,230,000 |
| Total NC Assets | $1,311,366 | $186,705,000 | $184,978,000 | $193,169,000 |
| Other Assets | $0 | $0 | -$1,000 | $0 |
| Total Assets | $2,630,566 | $408,123,000 | $409,277,000 | $398,307,000 |
| Liabilities | – | – | – | – |
| Payables | $206,937 | $42,361,000 | $38,989,000 | $35,791,000 |
| Short-Term Debt | $0 | $0 | $3,289,000 | $0 |
| Tax Payable | $3,092,000 | $0 | $2,239,000 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | -$2,801,557 | $44,070,000 | $42,320,000 | $42,738,000 |
| Total Curr. Liab. | $497,381 | $86,431,000 | $86,837,000 | $78,529,000 |
| LT Debt | $240,825 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $18,313 | $0 | $2,606,000 | $0 |
| Other NC Liab. | $24,464 | $41,478,000 | $34,653,000 | $36,567,000 |
| Total NC Liab. | $283,602 | $41,478,000 | $37,259,000 | $36,567,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $3,015,000 | $0 |
| Total Liabilities | $780,983 | $127,909,000 | $124,096,000 | $115,096,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $59,596 | $8,808,000 | $8,806,000 | $8,797,000 |
| Retained Earnings | $1,593,629 | $227,682,000 | $228,291,000 | $227,374,000 |
| AOCI | $329,455 | $43,944,000 | $40,509,000 | $47,841,000 |
| Other Equity | -$125,256 | $831,000 | $8,636,000 | $16,000 |
| Total Equity | $1,857,425 | $281,265,000 | $286,242,000 | $284,028,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$7,842 | -$1,051,000 | -$1,061,000 | -$817,000 |
| Total Liab. & Tot. Equity | $2,630,566 | $408,123,000 | $409,277,000 | $398,307,000 |
| Net Debt | -$63,319,175 | -$84,578,000 | -$89,708,000 | -$77,851,000 |